Category Archives: Proton Pump Inhibitors

Featured Stories
FDA Urged to Ban Powdered Caffeine

FDA Urged to Ban Powdered Caffeine

Pennsylvania Senator Robert Casey has written to the Food and Drug Administration (FDA) to urge the agency to ban powdered caffeine, a dietary supplement.

Read More

Post -Tonsillectomy Morphine Life-Threatening in Children

Post -Tonsillectomy Morphine can be Life-Threatening in Children, Study Finds

A new study published in Pediatrics suggests that morphine can result in life-threatening respiratory problems when given to children after a tonsillectomy.

Read More

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Having already spent around $3 billion on its DePuy Orthopaedics ASR hip implant recall, Johnson & Johnson is facing another potential debacle involving a metal-on-metal version of its Pinnacle Hip Replacement System. According to a report from Reuters, Johnson & Johnson and its DePuy unit already face some 1,600 metal-on-metal ...

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

West Virginia Man Claims Metal-on-Metal DePuy Pinnacle Hip Replacement Led to Pain, Elevated Cobalt Levels

A West Virginia man fitted with a metal-on-metal version of DePuy Orthopaedics’ Pinnacle Hip Implant System has filed suit against the company and its parent, Johnson & Johnson, alleging the device caused him to suffer pain and elevated cobalt levels. The Plaintiff is being represented by the national law ...

Read More

DeflateGate’s Effects Impact Legal Gambling and the Economy

DeflateGate’s Effects Impact Legal Gambling and the Economy

The NFL has initiated a probe into the New England Patriots following allegations that the team intentionally used overly deflated footballs.

Read More

Medtronic Sprint Fidelis Leads Vulnerable to Fracture after ICD Switch

Medtronic Sprint Fidelis leads are vulnerable to fracture following ICD switch, says a new study published in the June issue of the journal Heart Rhythm.

Read More

Smith & Nephew Recalls Metal-on-Metal Hip Implant Component

Medical device maker, Smith & Nephew, just issued a recall for a metal-on-metal hip implant component, a part of one of its all-metal hip replacement systems.

Read More

64 More Plavix Patients File Suit Over Bleeding Side Effects

Another Plavix lawsuit has been filed on behalf of 64 Plavix patients who allege bleeding side effects. Plavix (clopidogrel) is a blood thinner prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, such as the heart attacks and strokes it is ...

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Proton Pump Inhibitors Raise Infection Risk in Cirrhosis Patients

Proton Pump Inhibitors (PPIs) such as Prilosec, Aciphex, Prevacid, and Protonix, raise infection risks in cirrhosis patients, according to a new study that found the risk for serious infections affects patients with decompensated cirrhosis. PPI users suffer from a 66 … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged |

Meta-Analysis Finds Proton Pump Inhibitors Increase Risk of C. Difficile-Associated Diarrhea by 69%

A newly-published study has again shown that the use of popular heartburn drugs known as proton pump inhibitors can increase the likelihood that a person will develop Clostridium difficile-associated diarrhea.  The authors of the study, which appears in the American … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged |

Study Finds “Robust” Risk of C. difficile with Proton Pump Inhibitors, other Heartburn Drugs

A new study has found that taking acid reducing drugs, including proton pump inhibitors, can significantly increase the risk for Clostridium difficile (C. difficile) infection. The lead author of the study, which involved a meta-analysis of 30 separate studies, characterized … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged |

PPI Side Effect Warnings for Fractures, Hypomagnesaemia Issued in U.K.

U.K. regulators issued two warnings this week regarding serious Proton Pump Inhibitor (PPI) side effects. According to the Medical and Healthcare Products Regulatory Agency (MHRA), recent studies indicated a link between long-term use of PPIs and fractures of the hip, … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged |

Health Canada Warns PPIs May Cause C. Diff-Associated Diarrhea

Health Canada is warning Canadians that prescription stomach antacids called proton pump inhibitors (PPIs) may cause Clostridium difficile–associated diarrhea (CDAD). CDAD is a potentially serious gastrointestinal infection. C. diff is bacterium that can cause diarrhea and may lead to more … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

FDA Says Proton Pump Inhibitors May Cause C-difficile Diarrhea

Using popular heartburn drugs called proton pump inhibitors (PPIs) could put some users at risk of contracting Clostridium difficile–associated diarrhea (CDAD), a potentially serious gastrointestinal infection. In a Drug Safety Communication issued yesterday, the U.S. Food & Drug Administration (FDA) … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

Another Study Links Popular Heartburn Drugs to Hip Fractures

A new study is providing more evidence of an association between hip fractures in older women and the use of popular heartburn drugs known as proton pump inhibitors (PPIs). The study, published in the British Medical Journal, found that post-menopausal … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

Proton Pump Inhibitors Linked to Heart Birth Defects

Proton Pump Inhibitors (PPIs) have been being linked to heart birth defects, when taken by women in the first trimester of pregnancy, according to a recent study. Popular PPIs include Aciphex (rabeprazole), Nexium (esomeprazole), Prevacid (lansoprazole), Prilosec (omeprazole), and Protonix … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

Studies Show Many People Taking Proton Pump Inhibitors Don’t Need Them

Aciphex, Dexilant, Nexium, Prevacid, Prilosec, and Protonix, all part of a class of drugs known a < "http://www.yourlawyer.com/topics/overview/Proton_pump_inhibitors">proton pump inhibitors, may be overprescribed, some recent studies indicate. According to a report from Web MD, overuse of proton pump inhibitors, which … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

New Study Finds PPIs Increase Risk For C. Diff

Popular heartburn medications, < "http://www.yourlawyer.com/topics/overview/Proton_pump_inhibitors">Proton Pump Inhibitors (PPIs), have been linked to more adverse reactions; this time, Clostridium difficile (C. diff), in a large Japanese study presented at the annual Interscience Conference on Antimicrobial Agents and Chemotherapy. We recently wrote … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.